Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Peripheral Vascular Stents - Global Pipeline Analysis, Competitive LandscapeThe Global Peripheral Vascular Stents Market is Forecast to Reach $1.3 billion in 2017, After Growing at a CAGR of 4% During 2010-2017
By: Rajesh Gunnam The rapid increase in the aging population in developed markets such as the US, Germany, France, the UK, Italy and Japan, and the surge in high risk factors such as diabetes and smoking are contributing towards the increase in the incidence rate of PVD and stimulating the adoption of PVS. Fem-pop stents is the major segment within the PVS market and was globally valued at $387.2m in 2010. Launch of new fem-pop stents that allows greater treatment options and better clinical outcome has led to an increase in the confidence of the surgeons to perform superficial femoral artery (SFA) stenting procedures. The availability of improved stents which can be used in the treatment of longer and more tortuous lesions has increased the adoption of fem-pop stents in the treatment in femoral occlusion. Furthermore, new stents that address the concern of fem-pop stent fractures due to the size and power of thigh muscles have led to greater application of the fem-pop stents. For Sample Pages, please click or add the below link to your browser: http://www.globaldata.com/ The US PVS market was valued at $489.3m in 2010. The market has grown at a CAGR of 3% over the period 2003-2010. The US PVS market is expected to grow at a CAGR of 3% over the period 2010-2017, to reach $618m by 2017. The US was the biggest market for PVS in the period 2003-2010, and held 49% of the global market share in 2010. The US market grew due to increase in adoption of peripheral angioplasty over open surgeries and the rise in the prevalence of PVD due to the aging population. Cordis Corporation is the global leader in the PVS market, with a share of 19% in 2010. Abbott Vascular, Boston Scientific Corporation, C.R.Bard, Inc and Covidien plc (ev3, Inc) also have significant presence in the global PVS market. Cordis is an established player in this market with a broad product portfolio and a strong sales and distribution network. Cordis has a strong portfolio of products in the PVS market. The company offers all types of PVS with option for multiples sizes. The company offers lower extremity stents, carotid artery stents, iliac artery stents and renal artery stents. However, the current restructuring of it businesses involving exit from the drug eluting stents market deprives the company the potential to capitalize on the application of drug eluting stents towards PVD. GlobalData’s new report, “Peripheral Vascular Stents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global peripheral vascular stents market. The report provides market landscape, competitive landscape and market trends information on the peripheral vascular stents market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. For further details, please click or add the below link to your browser: http://www.globaldata.com/ Visit our report store: http://www.globaldata.com/ For more details contact: pressreleases@ North America: +1 646 395 5477 Europe: Asia Pacific: # # # GlobalData is a global market intelligence services company providing information research and analysis products and services. End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number